Publications

Filters

Publications Atlas Journal Article Research Report

Clinical and Practice Brain diseases Cancer and cancer screening Cardiovascular disease Chronic diseases and multimorbidity Diet and nutrition Endocrinology Environmental health Eye, ear, nose and throat disorders Gastroenterology Hematology Infectious diseases Injuries and accidents Internal medicine Kidney disease Lung health Musculoskeletal diseases and disorders Organ transplantation and donation Pharmacoepidemiology and drug safety Reproductive medicine Skin diseases and disorders

Healthcare Providers and Services Acute and emergency services End-of-life care Home and community care Long-term care and continuing care Maternity and neonatal care Mental health and addictions Nursing Pediatrics Pharmacy Primary care Public health Rehabilitation Surgery

People and Society Children and young people Health and healthcare inequality Indigenous Peoples Marginalized populations Older people Racialized communities Women or gender-based research

Research and Methods Data science Decision science Epidemiology Health economics Health services research Implementation science and knowledge translation Policy and program evaluation Statistics Trials

From

ICES Central ICES McMaster ICES North ICES Queen's ICES UofT ICES uOttawa ICES Western

Cancer Cardiovascular Chronic Disease & Pharmacotherapy Kidney, Dialysis & Transplantation Life Stage Mental Health & Addictions Populations & Public Health Primary Care & Health Systems

Showing 1-10 of 315

Journal Article

07/11/2025

Patient and prescriber characteristics associated with return to daily-dispense methadone: a multilevel cohort study

Garg R, Ledlie S, McCormack D, Bozinoff N, Wyman J, Sproule B, Leece P, Tadrous M, Smoke A, Munro C, Gomes T. PLOS Ment Health. 2025; 2(11): e0000442.

Journal Article

27/10/2025

Trends in prescription opioid use for pain in Canada: a population-based repeated cross-sectional study of 6 provinces

Rebic N, Hamzat B, Cheung G, Eurich D, Kabore J-L, de Leseleuc L, Liu Z, Missaoui H, Randall J, Shearer D, Stocke D, Yang J, Gomes T. CMAJ. 197(36):E1175-E1183.

Journal Article

07/10/2025

Impact of direct oral anticoagulant uptake on hospitalizations for stroke/transient ischemic attack, intracranial hemorrhage, and gastrointestinal bleeding in individuals with atrial fibrillation: a population-based study

Antoniou T, McCormack D, Wang T, Tadrous M, Gomes T. Fundam Clin Pharmacol. 2025; 39(6):e70051.

Journal Article

26/08/2025

Circumstances surrounding alcohol toxicity deaths and prior pharmacotherapy for alcohol use disorder in Ontario, Canada

Wynne W, Iacono A, Yang J, Hamzat B, Leece P, Kolla G, Boyd R, Bozinoff N, Franklyn M, Shearer D, Smoke A, Wu F, Newcombe P, Gomes T. Alcohol Alcohol. 2025; 60(5):agaf055.

Journal Article

22/08/2025

Evaluating regional and temporal variations in quality indicators for opioid initiation and pharmacist medication reviews in Ontario: a population-based repeated cross-sectional study

Torabi A, Chu C, Abdul Aziz Y, Yada N, Chaudhry S, Wang T, Gomes T, Tadrous M. Can Pharm J (Ott). 2025; 17151635251358873. Epub 2025 Aug 22.

Journal Article

18/08/2025

Trends in the dispensing of opioids for pain and concurrent benzodiazepine use among First Nations People in Ontario, Canada, from 2013 to 2021

Holton A, Wang T, Hamzat B, Bragg S, deGonzague B, Mecredy G, Campbell T, Antoniou T, McGregor L, Bertram J, Gomes T. Can J Public Health. 2025; Aug 18 [Epub ahead of print].

Journal Article

15/08/2025

Initiation and dose of methadone monotherapy vs combination therapy, 2015 to 2023

Garg R, Luo J, Bozinoff N, Sproule B, Antoniou T, Wyman J, Munro C, Gomes T. JAMA Netw Open. 2025; 8(8):e2527290.

Journal Article

27/07/2025

Circumstances surrounding opioid toxicity deaths within shelters in Ontario, Canada, before and during the COVID-19 pandemic: a population-based descriptive cross-sectional study

Hamzat B, Leece P, McCormack D, Holton A, Dodd Z, Firestone M, Smoke A, Wolfson-Stofko B, Smuts H, Sereda J, Watford J, Watts T, Gomes T. BMJ Public Health. 2025; 3(2):e002394.

Journal Article

10/07/2025

Assessing the impact of the introduction of generic methadone to the Ontario public drug formulary

Hamzat B, Wang T, Garg R, Iacono A, Tadrous M, Wu F, Wyman J, Dodd Z, Pinkerton S, Smoke A, Gomes T. Int J Drug Policy. 2025; 143:104918. Epub 2025 Jul 10.

Journal Article

30/06/2025

Retention in opioid agonist therapy among First Nations people in Ontario, Canada: a retrospective cohort study

Holton A, Hamzat B, McCormack D, Bragg S, deGonzague B, Mecredy G, Campbell T, Antoniou T, McGregor L, Bertram J, Gomes T. JAMA Netw Open. 2025; 8(6):e2518452.

« Previous 1 2 3 4 … 32 Next »

Publications

Filters

Resource Type

Topic

Date

ICES Scientists

ICES Site

Research Program

Patient and prescriber characteristics associated with return to daily-dispense methadone: a multilevel cohort study

Trends in prescription opioid use for pain in Canada: a population-based repeated cross-sectional study of 6 provinces

Impact of direct oral anticoagulant uptake on hospitalizations for stroke/transient ischemic attack, intracranial hemorrhage, and gastrointestinal bleeding in individuals with atrial fibrillation: a population-based study

Circumstances surrounding alcohol toxicity deaths and prior pharmacotherapy for alcohol use disorder in Ontario, Canada

Evaluating regional and temporal variations in quality indicators for opioid initiation and pharmacist medication reviews in Ontario: a population-based repeated cross-sectional study

Trends in the dispensing of opioids for pain and concurrent benzodiazepine use among First Nations People in Ontario, Canada, from 2013 to 2021

Initiation and dose of methadone monotherapy vs combination therapy, 2015 to 2023

Circumstances surrounding opioid toxicity deaths within shelters in Ontario, Canada, before and during the COVID-19 pandemic: a population-based descriptive cross-sectional study

Assessing the impact of the introduction of generic methadone to the Ontario public drug formulary

Retention in opioid agonist therapy among First Nations people in Ontario, Canada: a retrospective cohort study